Human herpesvirus 6A infection and immunopathogenesis in humanized Rag2-/- γc-/- mice

Journal of Virology

Volumn 87, Issue 22, 2013, Pages 12020-12028

  Tanner, Anne ^a   Carlson, Stephanie A ^a   Nukui, Masatoshi ^b   Murphy, Eain A ^b   Berges, Bradford K ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE COFACTOR PROTEIN; VIRUS DNA; DNA BINDING PROTEIN; RAG2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; BONE MARROW; CD4+ CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA DETERMINATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IMMUNOPATHOGENESIS; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; THYMUS; UMBILICAL CORD BLOOD; VIRUS INFECTION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; EXANTHEMA SUBITUM; FETUS BLOOD; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SPLEEN; TRANSMISSION; VIROLOGY;

ANIMALIA; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6A; MUS;

ANIMALS; BONE MARROW; CELLS, CULTURED; DNA, VIRAL; DNA-BINDING PROTEINS; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HERPESVIRUS 6, HUMAN; HUMANS; LYMPH NODES; MICE; MICE, INBRED BALB C; ROSEOLOVIRUS INFECTIONS; SPLEEN; THYMUS GLAND; VIRUS REPLICATION;

EID: 84886255547     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01556-13     Document Type: Article

References (50)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601.
2. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE. 1999. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J. Virol. 73:8040-8052.
3. Emery VC, Clark DA. 2007. Chapter 49. HHV-6A, 6B, and 7: persistence in the population, epidemiology and transmission. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
4. Burbelo PD, Bayat A, Wagner J, Nutman TB, Baraniuk JN, Iadarola MJ. 2012. No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Am. J. Transl. Res. 4:443-451.
5. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817-827.
6. Tang H, Serada S, Kawabata A, Ota M, Hayashi E, Naka T, Yamanishi K, Mori Y. 2013. CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc. Natl. Acad. Sci. U. S. A. 110:9096-9099.
7. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067.
8. Virtanen JO, Farkkila M, Multanen J, Uotila L, Jaaskelainen AJ, Vaheri A, Koskiniemi M. 2007. Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications. J. Neurovirol. 13:347-352.
9. Sola P, Merelli E, Marasca R, Poggi M, Luppi M, Montorsi M, Torelli G. 1993. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J. Neurol. Neurosurg. Psychiatry 56:917-919.
10. Behzad-Behbahani A, Mikaeili MH, Entezam M, Mojiri A, Pour GY, Arasteh MM, Rahsaz M, Banihashemi M, Khadang B, Moaddeb A, Nematollahi Z, Azarpira N. 2011. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J. Microbiol. Immunol. Infect. 44:247-251.
11. Appleton AL, Sviland L, Peiris JS, Taylor CE, Wilkes J, Green MA, Pearson AD, Kelly PJ, Malcolm AJ, Proctor SJ. 1995. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graftversus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. Bone Marrow Transpl. 16:777-782.
12. Agut H. 2011. Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. J. Clin. Virol. 52:164-171.
13. Le J, Gantt S, AST Infectious Diseases Community of Practice. 2013. Human herpesvirus 6, 7 and 8 in solid organ transplantation. Am. J. Transplant. 13(Suppl 4):128-137.
14. Razonable RR, Zerr DM, AST Infectious Diseases Community of Practice. 2009. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am. J. Transplant. 9(Suppl 4):S97-S100.
15. Saraya T, Mikoshiba M, Kamiyama H, Yoshizumi M, Tsuchida S, Tsukagoshi H, Ishioka T, Terada M, Tanabe E, Tomioka C, Ishii H, Kimura H, Kozawa K, Shiohara T, Takizawa H, Goto H. 2013. Evidence for reactivation of human herpesvirus 6 in generalized lymphadenopathy in a patient with drug-induced hypersensitivity syndrome. J. Clin. Microbiol. 51:1979-1982.
16. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH. 2007. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br. J. Dermatol. 157: 934-940.
17. Yao K, Crawford JR, KomaroffAL, Ablashi DV, Jacobson S. 2010. Review part 2: human herpesvirus-6 in central nervous system diseases. J. Med. Virol. 82:1669-1678.
18. Ablashi DV, Devin CL, Yoshikawa T, Lautenschlager I, Luppi M, Kühl U, KomaroffAL. 2010. Review part 3: human herpesvirus-6 in multiple non-neurological diseases. J. Med. Virol. 82:1903-1910.
19. Gobbi A, Stoddart CA, Malnati MS, Locatelli G, Santoro F, Abbey NW, Bare C, Linquist-Stepps V, Moreno MB, Herndier BG, Lusso P, McCune JM. 1999. Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J. Exp. Med. 189:1953-1960.
20. Emery VC, Atkins MC, Bowen EF, Clark DA, Johnson MA, Kidd IM, McLaughlin JE, Phillips AN, Strappe PM, Griffiths PD. 1999. Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6. J. Med. Virol. 57:278-282.
21. Lusso P, Gallo RC. 1995. Human herpesvirus 6 in AIDS. Immunol. Today 16:67-71.
22. Lusso P, Crowley RW, Malnati MS, Di Serio C, Ponzoni M, Biancotto A, Markham PD, Gallo RC. 2007. Human herpesvirus 6A accelerates AIDS progression in macaques. Proc. Natl. Acad. Sci. U. S. A. 104:5067-5072.
23. Lusso P, Markham PD, DeRocco SE, Gallo RC. 1990. In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo. J. Virol. 64:2751-2758.
24. Lusso P, Secchiero P, Crowley RW. 1994. In vitro susceptibility of Macaca nemestrina to human herpesvirus 6: a potential animal model of coinfection with primate immunodeficiency viruses. AIDS Res. Hum. Retroviruses 10:181-187.
25. Leibovitch E, Wohler JE, Cummings Macri SM, Motanic K, Harberts E, Gaitán MI, Maggi P, Ellis M, Westmoreland S, Silva A, Reich DS, Jacobson S. 2013. Novel marmoset (Callithrix jacchus) model of human herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization. PLoS Pathog. 9:e1003138. doi:10.1371/journal.ppat.1003138.
26. Berges BK, Rowan MR. 2011. The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology 8:65. doi:10.1186/1742-4690-8-65.
27. -/- mice as a model for Epstein-Barr virus infection. Am. J. Pathol. 173:1369-1378.
28. Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, Jankowska-Gan E, Burlingham WJ, Sun X, Gulley ML, Tang W, Gumperz JE, Kenney SC. 2011. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J. Virol. 85:165-177.
29. Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, Koo G, Rice CM, Young JW, Chadburn A, Cohen JI, Münz C. 2009. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J. Exp. Med. 206:1423-1434.
30. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H, Ito M, Shimizu N, Honda M, Yamamoto N, Fujiwara S. 2008. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cellmediated and humoral immune responses. J. Infect. Dis. 198:673-682.
31. +) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 108:141-151.
32. Parsons CH, Adang LA, Overdevest J, O'Connor CM, Taylor JRJ, Camerini D, Kedes DH. 2006. KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. J. Clin. Invest. 116:1963-1973.
33. Smith MS, Goldman DC, Bailey AS, Pfaffle DL, Kreklywich CN, Spencer DB, Othieno FA, Streblow DN, Garcia JV, Fleming WH, Nelson JA. 2010. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8:284-291.
34. Tang H, Kawabata A, Yoshida M, Oyaizu H, Maeki T, Yamanishi K, Mori Y. 2010. Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth. Virology 407:360-367.
35. Kalejta RF, Bechtel JT, Shenk T. 2003. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell. Biol. 23:1885-1895.
36. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. (Lond.) 27:493-497.
37. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104-107.
38. -/- (RAG-hu) mouse model. Retrovirology 3:76. doi:10.1186/1742-4690-3-76.
39. -/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes. PLoS One 6:e20169. doi:10.1371/journal.pone.0020169.
40. Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, Fillet AM, Mangeney N, Vidaud M, Dhedin N, Vernant JP, Agut H. 2002. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J. Virol. Methods 100:27-35.
41. Tsujimura A, Shida K, Kitamura M, Nomura M, Takeda J, Tanaka H, Matsumoto M, Matsumiya K, Okuyama A, Nishimune Y, Okabe M, Seya T. 1998. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem. J. 330:163-168.
42. Zhen Z, Bradel-Tretheway B, Sumagin S, Bidlack JM, Dewhurst S. 2005. The human herpesvirus 6 G protein-coupled receptor homolog U51 positively regulates virus replication and enhances cell-cell fusion in vitro. J. Virol. 79:11914-11924.
43. Adams O, Krempe C, Kögler G, Wernet P, Scheid A. 1998. Congenital infections with human herpesvirus 6. J. Infect. Dis. 178:544-546.
44. Braun DK, Dominguez G, Pellett PE. 1997. Human herpesvirus 6. Clin. Microbiol. Rev. 10:521-567.
45. + mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J. Immun. 147:685-691.
46. + T lymphocytes by human herpesvirus 6. Nature 349:533-535.
47. + T cells are differentiated effector memory cells with antiviral functions. Blood 104:478-486.
48. Grivel JC, Santoro F, Chen S, Fagá G, Malnati MS, Ito Y, Margolis L, Lusso P. 2003. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J. Virol. 77:8280-8289.
49. -/- mice. Proc. Natl. Acad. Sci. U. S. A. 103:15951-15956.
50. Zhang L, Kovalev GI, Su L. 2007. HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 109:2978-2981.